AnJie Broad Law Firm provides a comprehensive offering in this space, handling major patent disputes, licensing and collaboration agreements and financing assistance. Hang Cai is the key name to note on the investor side, advising venture capital and private equity firms. Experienced IP litigator Nick Liu, M&A lawyer Long Gu, anti-monopoly law expert Ying Song and the FDI focussed Sanny Liu are also key. Zongxiu Cai is recommended for IPO related work.
Legal 500 Editorial commentary
Key clients
- GlaxoSmithKline Consumer Healthcare (China) Co., Ltd.
- Wyeth Pharmaceutical Co., Ltd.
- Sino-American Tianjin SmithKline and French Lab., Ltd.
- Suzhou Yiduoyun Health Co., Ltd.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Suzhou Shengtuo Semiconductor Technology Co., Ltd.
- Shanghai Ebos Biotechnology Co., Ltd.
- Sanhome
- ACON Biotech (Hangzhou) Co.
- Shanghai Healthcare Capital
- LH Ventures capital
- Fosun Pharma
- 5Y Capital
Work highlights
- Assisted Sanhome with a pharmaceutical patent dispute, where the patent was initially invalidated by the State Intellectual Property Office of China and the Beijing Intellectual Property Court, but later validated by the Intellectual Property Division of the Supreme People's Court.
- Assisting Fosun Pharma's drugs incubator platform (Fosun Lead) with its licensing and development collaboration and its several portfolio enterprises' equity financing deals.
- Advised LH Venture on its series A investment of RMB 50 million in InnoBM.
Practice head
The lawyer(s) leading their teams.
Hang Cai, Nick Liu, Long Gu, Samuel Hang, Ying Song, Sanny Liu, Zongxiu Cai